University of Birmingham: Drug to Delay Type 1 Diabetes Approved for UK Use
June 24, 2026
June 24, 2026
BIRMINGHAM, England, June 24 -- The University of Birmingham posted the following news:
* * *
Drug to delay Type 1 Diabetes approved for UK use
NICE approves Teplizumab which was used under early access scheme for first time in UK in Birmingham
-
Diabetes experts at the University of Birmingham have welcomed news that a drug that can delay the progression to insulin requiring type 1 diabetes in individuals with early-stage disease . . .
* * *
Drug to delay Type 1 Diabetes approved for UK use
NICE approves Teplizumab which was used under early access scheme for first time in UK in Birmingham
-
Diabetes experts at the University of Birmingham have welcomed news that a drug that can delay the progression to insulin requiring type 1 diabetes in individuals with early-stage disease . . .